In infants with CHD, several inflammatory molecules, such as RANTES and macrophage migration inhibitory factor (MIF) related to pulmonary congestion or pulmonary vascular resistance, respectively—mechanisms known to be involved in the pathophysiology of pulmonary hypertension [24]. Here, MIF is linked to pulmonary hypertension.